Pengfei Sun
- Topics
- Hepatocellular Carcinoma Treatment and Prognosis (4 papers)MicroRNA in disease regulation (4 papers)Ferroptosis and cancer prognosis (4 papers)
- Cited by
- Cancer ResearchHepatologyImmunology
In The Last Decade
Pengfei Sun
23 papers receiving 327 citations
Peers
Comparison fields: 5 of 65
- Molecular Biology 178
- Cancer Research 108
- Oncology 73
- Immunology 70
- Hepatology 42
Countries citing papers authored by Pengfei Sun
This map shows the geographic impact of Pengfei Sun's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pengfei Sun with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pengfei Sun more than expected).
Fields of papers citing papers by Pengfei Sun
This network shows the impact of papers produced by Pengfei Sun. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pengfei Sun. The network helps show where Pengfei Sun may publish in the future.
Co-authorship network of co-authors of Pengfei Sun
This figure shows the co-authorship network connecting the top 25 collaborators of Pengfei Sun. A scholar is included among the top collaborators of Pengfei Sun based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pengfei Sun. Pengfei Sun is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 17 | |
| 2 | 0 | |
| 3 | 13 | |
| 4 | 6 | |
| 5 | 8 | |
| 6 | 11 | |
| 7 | 13 | |
| 8 | 2 | |
| 9 | 5 | |
| 10 | 16 | |
| 11 | 12 | |
| 12 | 13 | |
| 13 | 11 | |
| 14 | 23 | |
| 15 | 36 | |
| 16 | 24 | |
| 17 | 39 | |
| 18 | Targeting STAT3 restores BRAF inhibitor sensitivity through miR-759-3p in human cutaneous melanoma cells. | 4 |
| 19 | 15 | |
| 20 | 10 |
About Pengfei Sun
Pengfei Sun is a scholar working on Cancer Research, Hepatology and Toxicology, having authored 24 papers that have together received 328 indexed citations. Recurring topics across this work include Hepatocellular Carcinoma Treatment and Prognosis (4 papers), MicroRNA in disease regulation (4 papers) and Ferroptosis and cancer prognosis (4 papers). The work is most often cited by research in Cancer Research (108 citations), Hepatology (42 citations) and Immunology (70 citations). Pengfei Sun has collaborated with scholars based in China, Hong Kong and Germany. Frequent co-authors include Lei Li, Chengsheng Zhang, Zhongchao Li, Wuyuan Zhou, Xuetao Shi, Jingtao Zhong, Lei Li, Xiaofeng Dong, Kai Cui and Yao Zhang. Their work appears in journals such as Nature Communications, Journal of Clinical Oncology and Science Advances.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.